Analysts See $-0.08 EPS for CDTi Advanced Materials, Inc. (CDTI); Shorts at GENSCRIPT BIOTECH ORDINARY SHARES (GNNSF) Raised By 367.12%

May 14, 2018 - By Adrian Mccoy

CDTi Advanced Materials, Inc. (NASDAQ:CDTI) Logo

GENSCRIPT BIOTECH CORP ORDINARY SHARES (OTCMKTS:GNNSF) had an increase of 367.12% in short interest. GNNSF’s SI was 308,300 shares in May as released by FINRA. Its up 367.12% from 66,000 shares previously. With 100 avg volume, 3083 days are for GENSCRIPT BIOTECH CORP ORDINARY SHARES (OTCMKTS:GNNSF)’s short sellers to cover GNNSF’s short positions. The SI to GENSCRIPT BIOTECH CORP ORDINARY SHARES’s float is 0.04%. It closed at $3.44 lastly. It is down 0.00% since May 14, 2017 and is . It has underperformed by 11.55% the S&P500.




Analysts expect CDTi Advanced Materials, Inc. (NASDAQ:CDTI) to report $-0.08 EPS on May, 21.They anticipate $0.11 EPS change or 57.89% from last quarter’s $-0.19 EPS. After having $-0.09 EPS previously, CDTi Advanced Materials, Inc.’s analysts see -11.11% EPS growth. The stock increased 3.08% or $0.02 during the last trading session, reaching $0.67. About 169,701 shares traded or 16.16% up from the average. CDTi Advanced Materials, Inc. (NASDAQ:CDTI) has declined 62.22% since May 14, 2017 and is downtrending. It has underperformed by 73.77% the S&P500.

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life sciences research services and products. The company has market cap of $6.00 billion. It operates in four divisions: Life Sciences Research Services, Life Sciences Research Catalog Products, Preclinical Drug Development Services, and Industrial Synthetic Biology Products. It has a 229.33 P/E ratio. The Life Sciences Research Services segment provides research services in various categories, including gene synthesis, oligonucleotide synthesis, DNA sequencing, protein production, peptide synthesis, and antibody development.

More news for CDTi Advanced Materials, Inc. (NASDAQ:CDTI) were recently published by: Nasdaq.com, which released: “CDTi to Nominate Two New Directors to the Board” on May 07, 2018. Nasdaq.com‘s article titled: “University of Houston Taps CDTi Advanced Materials to Implement Emission Catalyst Technology for Department of …” and published on April 26, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.